Trintellix does not currently have a generic version available on the market [1].
When is the patent for Trintellix expected to expire?
The primary patent protecting Trintellix, which is used to treat major depressive disorder, is set to expire in 2035 [2]. DrugPatentWatch.com tracks patent expiry dates for many medications [3].
What is Trintellix and how does it work?
Trintellix, also known by its generic name vortioxetine, is a medication prescribed for the treatment of major depressive disorder in adults [1]. It is classified as a serotonin modulator and stimulator, working by affecting serotonin activity in the brain [1].
Are there any other treatments for major depressive disorder?
Several other medications are available for major depressive disorder, including selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) [4]. Examples include fluoxetine, sertraline, and duloxetine [4].
What are the potential side effects of Trintellix?
Common side effects reported with Trintellix include nausea, vomiting, constipation, and abnormal dreams [1]. Serious side effects are rare but can include serotonin syndrome, an allergic reaction, or increased bleeding risk [1].
Why do generic versions of drugs take so long to become available?
The availability of generic drugs is typically contingent on the expiration of patents held by the original manufacturer. These patents grant market exclusivity for a specified period, preventing other companies from producing and selling generic versions [3]. Litigation surrounding patent validity can also impact the timeline for generic entry [3].